1,811
Views
15
CrossRef citations to date
0
Altmetric
Clinical Study

Incidence and impact of acute kidney injury on patients with implantable left ventricular assist devices: a Meta-analysis

ORCID Icon, , ORCID Icon, , , , , , , , , , , , ORCID Icon & show all
Pages 495-512 | Received 26 Apr 2020, Accepted 05 May 2020, Published online: 20 May 2020

References

  • Sen A, Larson JS, Kashani KB, et al. Mechanical circulatory assist devices: a primer for critical care and emergency physicians. Crit Care. 2016;20(1):153.
  • Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4 Suppl):S1–S39. [20181499]
  • Timms D. A review of clinical ventricular assist devices. Med Eng Phys. 2011;33(9):1041–1047.
  • Kirklin JK, Pagani FD, Kormos RL, et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017;36(10):1080–1086.
  • Patel AM, Adeseun GA, Ahmed I, et al. Renal failure in patients with left ventricular assist devices. Clin J Am Soc Nephrol. 2013;8(3):484–496.
  • Mao H, Katz N, Kim JC, et al. Implantable left ventricular assist devices and the kidney. Blood Purif. 2014;37(1):57–66.
  • Tromp TR, de Jonge N, Joles JA. Left ventricular assist devices: a kidney’s perspective. Heart Fail Rev. 2015;20(4):519–532.
  • Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376(5):451–460.
  • Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail. 2017;19(5):595–602.
  • Maciver J, Ross HJ. Quality of life and left ventricular assist device support. Circulation. 2012;126(7):866–874.
  • Singhvi A, Trachtenberg B. Left ventricular assist devices 101: shared care for general cardiologists and primary care. J Clin Med. 2019;8(10):pii:E1720.
  • Kormos RL, Cowger J, Pagani FD, et al. The society of thoracic surgeons intermacs database annual report: evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant. 2019;38(2):114–126.
  • Soliman OII, Akin S, Muslem R, et al. Derivation and validation of a novel right-sided heart failure model after implantation of continuous flow left ventricular assist devices: the EUROMACS (European Registry for Patients with Mechanical Circulatory Support) right-sided heart failure risk score. Circulation. 2018;137(9):891–906.
  • Yalcin YC, Bunge JJH, Guven G, et al. Acute kidney injury following left ventricular assist device implantation: contemporary insights and future perspectives. J Heart Lung Transplant. 2019;38(8):797–805.
  • Genovese EA, Dew MA, Teuteberg JJ, et al. Early adverse events as predictors of 1-year mortality during mechanical circulatory support. J Heart Lung Transplant. 2010;29(9):981–988.
  • Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125(25):3191–3200.
  • Abbas A, Mahmoud A, Ahmed M, et al. Gastrointestinal bleeding during the index hospitalization for mechanical circulatory support devices implantation, a nationwide perspective. Dig Dis Sci. 2017;62(1):161–174.
  • Adegbala O, Olakanmi O, Akintoye E, et al. Trends, outcomes, and readmissions among left ventricular assist device recipients with acute kidney injury requiring hemodialysis. ASAIO journal (American Society for Artificial Internal Organs: 1992). 2019.
  • Ahmed A, Adegbala O, Akintoye E, et al. Gender differences in outcomes after implantation of left ventricular assist devices. Ann Thorac Surg. 2020;109(3):780–786.
  • Aissaoui N, Morshuis M, Schoenbrodt M, et al. Temporary right ventricular mechanical circulatory support for the management of right ventricular failure in critically ill patients. J Thorac Cardiovasc Surg. 2013;146(1):186–191.
  • Alba AC, Rao V, Ivanov J, et al. Predictors of acute renal dysfunction after ventricular assist device placement. J Card Fail. 2009;15(10):874–881.
  • Anjum A, Kurihara C, Critsinelis A, et al. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs. 2018;21(3):285–292.
  • Arnaoutakis GJ, George TJ, Kilic A, et al. Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices. Ann Thorac Surg. 2012;93(5):1549–1555. discussion 1555.
  • Asleh R, Schettle S, Briasoulis A, et al. Predictors and outcomes of renal replacement therapy after left ventricular assist device implantation. Mayo Clin Proc. 2019;94(6):1003–1014.
  • Baxter RD, Tecson KM, Still S, et al. Predictors and impact of right heart failure severity following left ventricular assist device implantation. J Thorac Dis. 2019;11(S6):S864–s870.
  • Borgi J, Tsiouris A, Hodari A, et al. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation. Ann Thorac Surg. 2013;95(1):163–169.
  • Briasoulis A, Inampudi C, Akintoye E, et al. Trends in utilization, mortality, major complications, and cost after left ventricular assist device implantation in the United States (2009–2014). Am J Cardiol. 2018;121(10):1214–1218.
  • Brisco MA, Kimmel SE, Coca SG, et al. Prevalence and prognostic importance of changes in renal function after mechanical circulatory support. Circ Heart Fail. 2014;7(1):68–75.
  • Catino AB, Ferrin P, Wever-Pinzon J, et al. Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support. Eur J Heart Fail. 2018;20(1):164–174.
  • Critsinelis A, Kurihara C, Volkovicher N, et al. Model of end-stage liver Disease-eXcluding International Normalized Ratio (MELD-XI) scoring system to predict outcomes in patients who undergo left ventricular assist device implantation. Ann Thorac Surg. 2018;106(2):513–519.
  • Demirozu ZT, Etheridge WB, Radovancevic R, et al. Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy. J Heart Lung Transplant. 2011;30(2):182–187.
  • Deng MC, Edwards LB, Hertz MI, et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant. 2005;24(9):1182–1187.
  • Deschka H, Holthaus AJ, Sindermann JR, et al. Can perioperative right ventricular support prevent postoperative right heart failure in patients with biventricular dysfunction undergoing left ventricular assist device implantation? J Cardiothorac Vasc Anesth. 2016;30(3):619–626.
  • Feller ED, Sorensen EN, Haddad M, et al. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. Ann Thorac Surg. 2007;83(3):1082–1088.
  • Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122(6):1186–1195.
  • Go PH, Hodari A, Nemeh HW, et al. Effect of preoperative albumin levels on outcomes in patients undergoing left ventricular device implantation. ASAIO J (Am Soc Artif Int Organs: 1992). 2015;61(6):734–737.
  • Haddad M, Hendry PJ, Masters RG, et al. Ventricular assist devices as a bridge to cardiac transplantation: the Ottawa experience. Artif Organs. 2004;28(2):136–141.
  • Hasin T, Topilsky Y, Schirger JA, et al. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012;59(1):26–36.
  • John R, Naka Y, Smedira NG, et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg. 2011;92(4):1406–1413; discussion 1413.
  • Kaltenmaier B, Pommer W, Kaufmann F, et al. Outcome of patients with ventricular assist devices and acute renal failure requiring renal replacement therapy. ASAIO J (Am Soc Artif Int Organs: 1992). 2000;46(3):330–333.
  • Kurihara C, Critsinelis AC, Kawabori M, et al. Frequency and consequences of right-sided heart failure after continuous-flow left ventricular assist device implantation. Am J Cardiol. 2018;121(3):336–342.
  • Lok SI, Martina JR, Hesselink T, et al. Single-centre experience of 85 patients with a continuous-flow left ventricular assist device: clinical practice and outcome after extended support. Eur J Cardiothorac Surg. 2013;44(3):e233–238.
  • Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885–896.
  • Muslem R, Caliskan K, Akin S, et al. Acute kidney injury and 1-year mortality after left ventricular assist device implantation. J Heart Lung Transplant. 2018;37(1):116–123.
  • Nadziakiewicz P, Szygula-Jurkiewicz B, Niklewski T, et al. Effects of left ventricular assist device support on end-organ function in patients with heart failure: comparison of pulsatile- and continuous-flow support in a single-center experience. Transplant Proc. 2016;48(5):1775–1780.
  • Naik A, Akhter SA, Fedson S, et al. Acute kidney injury and mortality following ventricular assist device implantation. Am J Nephrol. 2014;39(3):195–203.
  • Ono M, Joshi B, Brady K, et al. Cerebral blood flow autoregulation is preserved after continuous-flow left ventricular assist device implantation. J Cardiothorac Vasc Anesth. 2012;26(6):1022–1028.
  • Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54(4):312–321.
  • Park SJ, Milano CA, Tatooles AJ, et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5(2):241–248.
  • Popov AF, Hosseini MT, Zych B, et al. Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg. 2012;93(3):810–815.
  • Raichlin E, Baibhav B, Lowes BD, et al. Outcomes in Patients with Severe Preexisting Renal Dysfunction After Continuous-Flow Left Ventricular Assist Device Implantation. ASAIO J (Am Soc Artif Int Organs: 1992). 2016;62(3):261–267.
  • Sandner SE, Zimpfer D, Zrunek P, et al. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant. 2008;27(5):469–473.
  • Schechter MA, Daneshmand MA, Patel CB, et al. Outcomes after implantable left ventricular assist device replacement procedures. ASAIO J (Am Soc Artif Int Organs: 1992). 2014;60(1):44–48.
  • Schmack B, Grossekettler L, Weymann A, et al. Prognostic relevance of hemodialysis for short-term survival in patients after LVAD implantation. Sci Rep. 2018;8(1):8546.
  • Shehab S, Macdonald PS, Keogh AM, et al. Long-term biventricular HeartWare ventricular assist device support-Case series of right atrial and right ventricular implantation outcomes. J Heart Lung Transplant. 2016;35(4):466–473.
  • Shehab S, Rao S, Macdonald P, et al. Outcomes of venopulmonary arterial extracorporeal life support as temporary right ventricular support after left ventricular assist implantation. J Thorac Cardiovasc Surg. 2018;156(6):2143–2152.
  • Silver SA, Long J, Zheng Y, et al. Outcomes after left ventricular assist device implantation in patients with acute kidney injury. J Thorac Cardiovasc Surg. 2019. 2019;S0022–5223(19)30742–1.
  • Slaughter MS, Pagani FD, McGee EC, et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2013;32(7):675–683.
  • Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–2251.
  • Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;57(19):1890–1898.
  • Strueber M, Larbalestier R, Jansz P, et al. Results of the post-market Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE). J Heart Lung Transplant. 2014;33(5):486–491.
  • Strueber M, HeartWare Investigators, O'Driscoll G, Jansz P, Khaghani A. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol. 2011;57(12):1375–1382.
  • Sumida M, Doi K, Kinoshita O, et al. Perioperative plasma neutrophil gelatinase-associated lipocalin measurement in patients who undergo left ventricular assist device implantation surgery. Circ J. 2014;78(8):1891–1899.
  • Topkara VK, Coromilas EJ, Garan AR, et al. Preoperative proteinuria and reduced glomerular filtration rate predicts renal replacement therapy in patients supported with continuous-flow left ventricular assist devices. Circ-Heart Fail. 2016;9(12):e002897.
  • Topkara VK, Dang NC, Barili F, et al. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant. 2006;25(4):404–408.
  • Tsiouris A, Brewer RJ, Borgi J, et al. Continuous-flow left ventricular assist device implantation as a bridge to transplantation or destination therapy: racial disparities in outcomes. J Heart Lung Transplant. 2013;32(3):299–304.
  • Verma S, Bassily E, Leighton S, et al. Renal function and outcomes with use of left ventricular assist device implantation and inotropes in end-stage heart failure: a retrospective single center study. J Clin Med Res. 2017;9(7):596–604.
  • Walther CP, Winkelmayer WC, Niu J, et al. Acute kidney injury with ventricular assist device placement: national estimates of trends and outcomes. Am J Kidney Dis. 2019;74(5):650–658.
  • Yuan N, Arnaoutakis GJ, George TJ, et al. The spectrum of complications following left ventricular assist device placement. J Card Surg. 2012;27(5):630–638.
  • Zhigalov K, Szczechowicz M, Mashhour A, et al. Left ventricular assist device implantation with concomitant tricuspid valve repair: is there really a benefit? J Thorac Dis. 2019;11(S6):S902–s912.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
  • Bellomo R, Ronco C, Kellum JA, et al. Acute dialysis quality initiative w. acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–212.
  • Mehta RL, Kellum JA, Shah SV, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31
  • Hu MC, Moe OW. Klotho as a potential biomarker and therapy for acute kidney injury. Nat Rev Nephrol. 2012;8(7):423–429.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet (London, England). 1991;337(8746):867–872.
  • Bresson D, Sibellas F, Farhat F, et al. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit . Arch Cardiovasc Dis. 2011;104(8–9):458–464.
  • Cohen MG, Matthews R, Maini B, et al. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: real-world versus clinical trial experience. Am Heart J. 2015;170(5):872–879.
  • Flaherty MP, Pant S, Patel SV, et al. Hemodynamic support with a microaxial percutaneous left ventricular assist device (Impella) protects against acute kidney injury in patients undergoing high-risk percutaneous coronary intervention. Circ Res. 2017;120(4):692–700.
  • Iliodromitis KE, Kahlert P, Plicht B, et al. High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support. Int J Cardiol. 2011;153(1):59–63.
  • Kusa S, Miller MA, Whang W, et al. Outcomes of ventricular tachycardia ablation using percutaneous left ventricular assist devices. Circul-Arrhythmia Elec. 2017;10(6):pii:e004717.
  • Miller MA, Dukkipati SR, Chinitz JS, et al. Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circ Arrhythm Electrophysiol. 2013;6(1):151–159.
  • O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126(14):1717–1727.
  • Parascandola SA, Pae WE, Jr., Davis PK, et al. Determinants of survival in patients with ventricular assist devices. ASAIO Trans. 1988;34(3):222–228.
  • Pieri M, Contri R, Winterton D, et al. The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience. BMC Cardiovasc Disord. 2015;15:126
  • Schiller P, Hellgren L, Vikholm P. Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score. Eur Heart J Acute Cardiovasc Care. 2019;8(4):329–337.
  • Nigwekar SU, Kandula P, Hix JK, et al. Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized and observational studies. Am J Kidney Dis: Off J Nat Kidney Found. 2009;54(3):413–423.
  • Tecson KM, Lima B, Lee AY, et al. Determinants and outcomes of vasoplegia following left ventricular assist device implantation. J Am Heart Assoc. 2018;7(11):pii:e008377.
  • Meineri M, Van Rensburg AE, Vegas A. Right ventricular failure after LVAD implantation: prevention and treatment. Best Pract Res Clin Anaesthesiol. 2012;26(2):217–229.
  • Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355(3):260–269.
  • Goldstein SL. Medication-induced acute kidney injury. Curr Opin Crit Care. 2016;22(6):542–545.
  • Nickel NP, O'Leary JM, Brittain EL, et al. Kidney dysfunction in patients with pulmonary arterial hypertension. Pulm Circ. 2017;7(1):38–54.
  • Kopitkó C, Gondos T, Fülöp T, et al. Reinterpreting renal hemodynamics: the importance of venous congestion and effective organ perfusion in acute kidney injury. Am J Med Sci. 2020;359(4):193–205.
  • Ross DW, Stevens GR, Wanchoo R, et al. Left ventricular assist devices and the kidney. Clin J Am Soc Nephrol. 2018;13(2):348–355.
  • Cooper TK, Zhong Q, Nabity M, et al. Use of urinary biomarkers of renal ischemia in a lamb preclinical left ventricular assist device model. Artif Organs. 2012;36(9):820–824.
  • Ootaki C, Yamashita M, Ootaki Y, et al. Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg. 2008;136(1):150–158.
  • Schima H, Dimitrov K, Zimpfer D. Debate: creating adequate pulse with a continuous flow ventricular assist device: can it be done and should it be done? Probably not, it may cause more problems than benefits!. Curr Opin Cardiol. 2016;31(3):337–342.
  • Sandner SE, Zimpfer D, Zrunek P, et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg. 2009;87(4):1072–1078.
  • Thongprayoon C, Cheungpasitporn W, Kashani K. Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients. J Thorac Dis. 2016;8(5):E305–E311.
  • Cheungpasitporn W, Kashani K. Electronic data systems and acute kidney injury. Contrib Nephrol. 2016;187:73–83.
  • Thongprayoon C, Cheungpasitporn W, Kittanamongkolchai W, et al. Prognostic importance of low admission serum creatinine concentration for mortality in hospitalized patients. Am J Med. 2017;130(5):545–554 e541.
  • Thongprayoon C, Hansrivijit P, Kovvuru K, et al. Diagnostics, risk factors, treatment and outcomes of acute kidney injury in a new paradigm. J Clin Med. 2020;9(4):1104.
  • Thongprayoon C, Kaewput W, Thamcharoen N, et al. Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis. J Clin Med. 2019;8(3):372.
  • Kashani K, Cheungpasitporn W, Ronco C. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med. 2017;55(8):1074–1089.
  • Thongprayoon C, Kaewput W, Kovvuru K, et al. Promises of big data and artificial intelligence in nephrology and transplantation. J Clin Med. 2020;9(4):1107.